The morbidity and associated risk factors of cancer in chronic liver disease patients with diabetes mellitus: a multicenter field survey-Reference-Cited by-同舟云学术

The morbidity and associated risk factors of cancer in chronic liver disease patients with diabetes mellitus: a multicenter field survey

Published:2014-06-10 Issue:3 Volume:50 Page:333-341
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Kawaguchi Takumi,Kohjima Motoyuki,Ichikawa Tatsuki,Seike Masataka,Ide Yasushi,Mizuta Toshihiko,Honda Koichi,Nakao Kazuhiko,Nakamuta Makoto,Sata Michio

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s00535-014-0968-5.pdf

Reference44 articles.

1. Sasazuki S, Charvat H, Hara A et al. Diabetes mellitus and cancer risk: pooled analysis of eight cohort studies in Japan. Cancer Sci. 2013;104:1499–507.

2. Nakamura K, Wada K, Tamai Y, et al. Diabetes mellitus and risk of cancer in Takayama: a population-based prospective cohort study in Japan. Cancer Sci. 2013;104:1362–7.

3. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006;4:369–80.

4. Ben Q, Xu M, Ning X, et al. Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur J Cancer. 2011;47:1928–37.

5. Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol. 2012;57:69–76.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Attributable liver cancer deaths and disability-adjusted life years in China and worldwide: profiles and changing trends;Cancer Biology & Medicine;2024-07-16

2. Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: Emerging approach for new application;Biomedicine & Pharmacotherapy;2022-01

3. Obesity and Liver Cancer in Japan: A Comprehensive Review;Anticancer Research;2021-05

4. Epidemiology, Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan;International Journal of Molecular Sciences;2020-06-18

5. Hepatoprotective Effect of SGLT2 Inhibitor on Nonalcoholic Fatty Liver Disease;SGLT2 inhibitors;2020-03-05